-
Medicine Development and Access for Rare Diseases: Can We Do Better?
Hollak, C. E. M., Rosenberg, N., Post, C., Stolwijk, N., Manders, E., Schoenmakers, D., Penninx, B., Reijnhout, N., Verdeyen, K., Jonker, R., Bosch, A. M., Langeveld, M., van der Wel, V., de Visser, S. & van den Berg, S., Mar 2026, In: Journal of inherited metabolic disease. 49, 2, p. e70146 e70146.Research output: Contribution to Journal › Review article › Academic › peer-review
-
Effect of a prediction tool and communication skills training on communication of treatment outcomes: a multicenter stepped wedge clinical trial (the SOURCE trial)
van de Water, L. F., Kuijper, S. C., Henselmans, I., van Alphen, E. N., Kooij, E. S., Calff, M. M., Beerepoot, L. V., Buijsen, J., Eshuis, W. J., Geijsen, E. D., Havenith, S. H. C., Heesakkers, F. F. B. M., Mook, S., Muller, K., Post, H. C., Rütten, H., Slingerland, M., van Voorthuizen, T., van Laarhoven, H. W. M. & Smets, E. M. A., 1 Oct 2023, In: EClinicalMedicine. 64, 102244.Research output: Contribution to Journal › Article › Academic › peer-review
-
Time to reimbursement of novel anticancer drugs in Europe: a case study of seven European countries
Post, H. C., Schutte, T., van Oijen, M. G. H., van Laarhoven, H. W. M. & Hollak, C. E. M., 1 Apr 2023, In: ESMO open. 8, 2, 101208.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications
